The Smartest Growth Stock to Buy With $1,000 Right Now

Well Health Technologies stock continues to rally as the company announces more growth through acquisitions.

| More on:
Female raising hands enjoying vacation, standing on background of blue cloudless sky.

Source: Getty Images

As a Canadian growth stock, Well Health Technologies Corp. (TSX:WELL) has been delivering far beyond expectations for quite some time now. This performance has been driven by soaring demand for the company’s digital solutions, as well as an aggressive acquisition strategy.

Well Health stock has rallied 70% in the last year. Read on as I share why I believe this is the smartest growth stock to buy today.

Digitizing the healthcare system

Well Health started out with a simple but noble goal – modernize the healthcare system. This means getting technology to work for doctors, patients, and clinics. And Well Health’s growth in the last five years has shown that this company was onto something big.

Since 2020, just five or so years ago, Well Health reported annual revenue of $50 million. In 2023, Well Health reported revenue of $776 million. That’s 1,452% higher, for a compound annual growth rate of 149% during this time period. We can clearly see that the healthcare system has been dying for the technological help that Well Health offers.

More acquisitions fuel growth

As part of Well Health’s strategy, the company has continued to make acquisitions. In the last month alone, the company has made seven acquisitions, which represent $100 million in annual revenue, at EBITDA margins of between 12.5% and 13%.

The acquisitions included one of the largest physician recruitment firms in Canada and two Canadian primary care clinics. Altogether, 75 new clinics were added to Well Health’s Canadian business. As a reminder, the primary care market in Canada is a large opportunity for Well Health, as it remains a pretty much untapped market. Long term, Well Health is targeting revenue of $4 billion from Canadian primary care. This is approximately 10 times current levels and would still only represent 5% of the market.

The recent acquisitions have allowed Well Health to capture a meaningful share of this market. Also, they expand the company’s geographic footprint and deepen its range of healthcare services.

Financial matters: Funding growth with cash

Importantly, all of these acquisitions were paid for with cash. Also, the company estimates that its leverage ratio is less than the leverage ratio announced at its last quarterly release. This is a reflection of the strong and growing cash flows that the business has been generating.

Looking ahead, Well Health’s mergers and acquisitions pipeline includes 12 letters of intent (LOI). These LOIs represent approximately $65 million in revenue. Clearly, the company’s growth is going strong. 2025 should be another strong year.

Guidance

So, what kind of growth can we expect from Well Health? Well, management’s guidance for 2024 is for revenue of between $985 million to $995 million. This represents an annual growth rate of between 26.9% and 28.2%.

Also, its adjusted EBITDA guidance is $125 million to $130 million. This represents an annual growth rate of between 10.2% and 14.6%. Well Health stock trades at 33 times 2024 estimated earnings. This is not cheap but considering that there’s very likely upside to earnings estimates, I think it is well worth the current price.

The bottom line

Well Health is a growth stock that I think everyone should consider buying. It’s up big in the last year, with more room to move considerably higher over time.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Karen Thomas has a position in Well Health Technologies. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Tech Stocks

cryptocurrency, crypto, blockcahin
Tech Stocks

Earn an 11% Yield With This Bitcoin-Focused ETF

This ETF converts the high volatility of Bitcoin into above-average monthly income.

Read more »

A close up color image of a small green plant sprouting out of a pile of Canadian dollar coins "loonies."
Tech Stocks

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

Are you wondering what stocks could skyrocket in 2025? Here are some ideas on picking long-term winners for your portfolio.

Read more »

data center server racks glow with light
Tech Stocks

Where Will Constellation Software Stock Be in 10 Years?

Constellation Software (TSX:CSU) stock still looks way too cheap after pulling back further.

Read more »

how to save money
Tech Stocks

3 Reasons to Buy Shopify Stock Like There’s No Tomorrow

Here are three reasons why Shopify (TSX:SHOP) still looks like a solid buy in this current environment.

Read more »

Piggy bank with word TFSA for tax-free savings accounts.
Dividend Stocks

TFSA: 4 Ways to Make Bank, With Stocks to Match

Looking for some long-term holds for your TFSA? These four can create the perfect porfolio!

Read more »

Confused person shrugging
Tech Stocks

Dye & Durham Stock Is Down: Should You Buy the Dip or Run for Cover? 

Dye & Durham stock is down more than 25% in just one month. Is this dip an opportunity to buy…

Read more »

a-developer-typing-lines-of-ai-code-while-viewing-multiple-computer-monitors
Tech Stocks

Billionaires Are Selling Amazon Stock and Buying This TSX Stock in Bulk

These two tech stocks are both heavily into e-commerce and artificial intelligence, but one simply has more room to grow…

Read more »

person on phone leaning against outside wall with scenic view at airbnb rental property
Tech Stocks

3 Canadian Growth Stocks to Buy for Long-Term Returns

These three growth stocks may be down now, but don't count them out, especially for long-term growth.

Read more »